tiprankstipranks
Trending News
More News >
Uluru Co., Ltd. (JP:3979)
:3979
Japanese Market

Uluru Co., Ltd. (3979) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3979

Uluru Co., Ltd.

(3979)

Select Model
Select Model
Select Model
Outperform 78 (OpenAI - 5.2)
Rating:78Outperform
Price Target:
¥438.00
▲(4.78% Upside)
Action:ReiteratedDate:11/13/25
Uluru Co., Ltd. demonstrates strong financial performance with robust revenue growth and effective cash flow management, contributing significantly to the overall score. The technical analysis supports a positive trend, though caution is advised due to potential overbought conditions. The valuation is reasonable, offering a fair return but not indicating a significant discount. The absence of earnings call and corporate events data did not impact the score.
Positive Factors
Consistent revenue growth
Consistent double-digit revenue growth (c.12-13%) indicates expanding demand and product-market fit, providing durable top-line momentum. Over the next 2-6 months this supports reinvestment, scale economics and reduces execution risk versus peers with stagnant sales.
High gross profit margin
Very high gross margin (~69.8%) signals structural cost advantages or high-value services with pricing power. Sustained margin levels enable operating leverage as revenue grows, supporting persistent cash generation and resilience to input cost shocks over multiple quarters.
Strong balance sheet / low leverage
Low leverage and a near-50% equity ratio provide durable financial flexibility to fund growth, acquisitions or withstand downturns without refinancing strain. This balance-sheet strength preserves strategic optionality and reduces liquidity risk over the medium term.
Negative Factors
Declining return on equity
ROE falling to 15.13% suggests the company is generating lower returns on shareholder capital. Persistently weaker ROE can limit long-term shareholder value creation and indicates management must improve asset utilization or profit conversion to sustain investor returns.
Pressure on operating and net margins
Reported declines in EBIT and net profit margins indicate rising operating costs or weaker operational efficiency despite strong gross margins. If these trends persist, they will compress sustainable profitability and reduce funds available for reinvestment or dividends.
Slowing free cash flow growth
Positive free cash flow (¥509.35m) is offset by a meaningful slowdown in its growth rate. Declining FCF growth can constrain capital allocation choices—capex, M&A, dividends—and signals potential erosion in the company’s cash-generation momentum over coming quarters.

Uluru Co., Ltd. (3979) vs. iShares MSCI Japan ETF (EWJ)

Uluru Co., Ltd. Business Overview & Revenue Model

Company DescriptionULURU.CO.,LTD. provides crowd sourcing, BPO, data entry agency, and scanning services in Japan. The company offers Nyusatsu Joho Sokuho services that uses crowdworkers for the provision of up-to-date information about bids and winning bids for public-sector tenders and other bid solicitations; fondesk telephone call answering services that uses crowdworkers; en-photo photo sales management system for nursery schools and kindergartens; and OurPhoto service for matching individuals and professional photographers. It also provides outsourced business processes for the non-core activities of client companies, such as data entry and data scanning; and crowdsourcing services, which offers a platform for matching the requirements of client companies that want to place orders for specific tasks with suitable crowdworkers. ULURU.CO.,LTD. was incorporated in 2001 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyUluru Co., Ltd. generates revenue through multiple channels, primarily from the sales of its pharmaceutical products and services. The company’s key revenue streams include direct sales of its proprietary medications, licensing agreements with other pharmaceutical firms for the use of its technologies, and partnerships with research institutions for joint development projects. Additionally, Uluru may benefit from milestone payments and royalties as part of its collaborations with larger healthcare companies, which can significantly contribute to its earnings. The company's focus on innovative treatment solutions and strategic alliances plays a critical role in enhancing its market position and driving financial growth.

Uluru Co., Ltd. Financial Statement Overview

Summary
Uluru Co., Ltd. exhibits a robust financial profile with strong revenue growth and efficient cash flow management. While the company maintains a stable balance sheet with low leverage, challenges in profitability and declining return on equity highlight areas for improvement. Overall, the financial outlook remains positive, with opportunities to enhance operational efficiency and profitability.
Income Statement
85
Very Positive
Uluru Co., Ltd. has consistently demonstrated strong revenue growth, with an impressive revenue growth rate of 12.85% from 2024 to 2025. The gross profit margin stands at 69.78%, indicating efficient cost management. However, a decline in EBIT and net profit margins suggests potential challenges in operational efficiency and profitability.
Balance Sheet
78
Positive
The company maintains a healthy equity position with an equity ratio of 48.51% and a low debt-to-equity ratio of 0.05, reflecting strong financial stability. However, the return on equity has decreased to 15.13%, indicating a need for better utilization of equity capital to generate profits.
Cash Flow
82
Very Positive
Uluru Co., Ltd. has achieved positive free cash flow of 509.35 million, demonstrating strong cash generation capabilities. The operating cash flow to net income ratio is 1.42, indicating effective cash operations. However, the significant reduction in free cash flow growth rate from the previous year signals potential challenges in sustaining cash flow levels.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue6.91B6.70B5.94B4.86B4.03B3.22B
Gross Profit4.87B4.68B4.25B3.49B2.84B2.24B
EBITDA990.74M937.14M1.35B103.33M-174.09M199.50M
Net Income601.99M458.07M720.11M-45.51M-64.40M42.20M
Balance Sheet
Total Assets6.50B6.24B6.05B4.62B4.34B4.20B
Cash, Cash Equivalents and Short-Term Investments3.69B3.41B3.59B2.40B2.81B3.29B
Total Debt148.33M158.33M198.33M38.88M80.69M123.01M
Total Liabilities3.35B3.21B3.24B2.53B2.21B1.99B
Stockholders Equity3.15B3.03B2.81B2.09B2.13B2.21B
Cash Flow
Free Cash Flow389.00M509.35M1.10B41.92M-105.49M643.99M
Operating Cash Flow532.00M651.91M1.47B328.86M-30.70M701.83M
Investing Cash Flow-420.00M-553.08M-441.29M-695.05M-416.77M-196.43M
Financing Cash Flow-154.00M-283.60M160.11M-42.85M-39.20M-78.59M

Uluru Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price418.00
Price Trends
50DMA
412.76
Negative
100DMA
415.21
Negative
200DMA
405.25
Negative
Market Momentum
MACD
-8.83
Positive
RSI
28.94
Positive
STOCH
18.29
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3979, the sentiment is Negative. The current price of 418 is above the 20-day moving average (MA) of 403.45, above the 50-day MA of 412.76, and above the 200-day MA of 405.25, indicating a bearish trend. The MACD of -8.83 indicates Positive momentum. The RSI at 28.94 is Positive, neither overbought nor oversold. The STOCH value of 18.29 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3979.

Uluru Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
¥7.21B8.993.37%5.25%23.64%
78
Outperform
¥10.69B15.660.59%12.09%30.56%
76
Outperform
¥24.94B14.821.70%22.25%31.88%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
¥10.06B16.072.32%126.46%
58
Neutral
¥15.72B32.559.82%-32.60%
39
Underperform
¥7.44B-2.28-29.41%79.74%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3979
Uluru Co., Ltd.
383.00
-36.77
-8.76%
JP:1447
ITbook Holdings Co., Ltd.
408.00
87.00
27.10%
JP:4053
Sun Asterisk, Inc.
417.00
-125.00
-23.06%
JP:4396
System Support, Inc.
1,301.00
313.28
31.72%
JP:4752
Showa System Engineering Corporation
1,621.00
266.16
19.65%
JP:5255
Monstarlab Holdings Inc.
133.00
49.00
58.33%

Uluru Co., Ltd. Corporate Events

Uluru Raises FY2026 Profit and Dividend Forecasts on Strong Performance
Feb 13, 2026

Uluru Co., Ltd. has revised its full-year consolidated earnings forecast for the fiscal year ending March 31, 2026, maintaining net sales guidance at ¥7,710 million while raising the lower bounds of EBITDA, operating income, ordinary income and profit attributable to owners of parent. The move reflects stronger-than-expected progress through the third quarter and increases projected earnings per share to a range of ¥19.87 to ¥21.68 after accounting for a 4-for-1 stock split implemented in October 2025.

Management said the likelihood of hitting full-year targets has risen, prompting it to narrow the forecast ranges while still preserving room for flexible investment aimed at medium- to long-term growth. In tandem with the earnings upgrade, the company lifted its year-end dividend forecast from ¥2.75 to ¥3.00 per share, signaling confidence in profitability and offering incremental returns to shareholders versus the prior year’s ¥2.50 payout on a post-split basis.

The most recent analyst rating on (JP:3979) stock is a Buy with a Yen449.00 price target. To see the full list of analyst forecasts on Uluru Co., Ltd. stock, see the JP:3979 Stock Forecast page.

Uluru Releases Q3 FY2026 Results and Highlights NJSS Growth Strategy
Feb 13, 2026

Uluru Co., Ltd. has released its financial results for the third quarter of the fiscal year ending March 31, 2026, providing consolidated financial highlights and business segment performance data. The disclosure also outlines key performance indicators, notable topics, and a dedicated growth strategy for the NJSS business, signaling management’s emphasis on scaling this core service and reinforcing the company’s competitive position in its market.

The materials indicate a structured approach to investor communication, including detailed appendices and availability of financial data in Excel format on the company’s website. This comprehensive information package is likely intended to enhance transparency for shareholders and analysts, support evaluation of the company’s operational progress, and clarify how the NJSS-focused strategy may drive future growth and value creation.

The most recent analyst rating on (JP:3979) stock is a Buy with a Yen449.00 price target. To see the full list of analyst forecasts on Uluru Co., Ltd. stock, see the JP:3979 Stock Forecast page.

Uluru boosts earnings outlook and dividend after strong third quarter
Feb 13, 2026

Uluru Co., Ltd. reported solid results for the nine months ended December 31, 2025, with net sales rising 14.3% year on year to ¥5,442 million and profit attributable to owners of parent jumping 79.3% to ¥507 million, lifting net income per share to ¥18.32. The balance sheet also expanded, with total assets increasing to ¥7,320 million and shareholders’ equity to ¥3,465 million, though the equity ratio edged down to 47.3% amid growth investments.

The company revised its full-year forecast, now projecting net sales of ¥7,710 million and profit attributable to owners of parent of ¥550–600 million, implying continued double-digit earnings growth. It also raised its dividend outlook, reflecting a 4-for-1 stock split effective October 1, 2025, and signaled confidence in future cash flows and shareholder returns while integrating its new subsidiary and adjusting accounting estimates.

The most recent analyst rating on (JP:3979) stock is a Buy with a Yen449.00 price target. To see the full list of analyst forecasts on Uluru Co., Ltd. stock, see the JP:3979 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 13, 2025